Literature DB >> 28835672

Osteoporosis: Discontinuing denosumab discouraged.

Joanna Collison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28835672     DOI： 10.1038/nrrheum.2017.144

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

Review 1.  Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS.

Authors:  Elena Tsourdi; Bente Langdahl; Martine Cohen-Solal; Bérengere Aubry-Rozier; Erik Fink Eriksen; Nuria Guañabens; Barbara Obermayer-Pietsch; Stuart H Ralston; Richard Eastell; M Carola Zillikens
Journal:  Bone       Date:  2017-08-05       Impact factor: 4.398
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.